ArticleLeukemia2021

BTK gatekeeper residue variation combined with cysteine 481 substitution causes super-resistance to irreversible inhibitors acalabrutinib, ibrutinib and zanubrutinib.

H Yesid Estupiñán et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.